Genmab and CureVac Enter Strategic Partnership to Develop mRNA-based Antibody Therapeutics

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 8/19/2026

1. NVDA
2. METC
3. SPY
4. DOO
5. HD
6. AMLX
7. ARGX
8. INFQ

Go back to Genmab and CureVac Enter Strategic Partnership to Develop mRNA-based Antibody Therapeutics
(NASDAQ: GMAB) Delayed: 32.96 +0.12 (0.37%)
Previous Close $32.84    52 Week High $ 
Open $32.86    52 Week Low $ 
Day High $33.11    P/E N/A 
Day Low $32.66    EPS $ 
Volume 2,706,951       

(NASDAQ: GMAB) Delayed: 32.96 +0.12 (0.37%)
Previous Close $32.84    52 Week High $ 
Open $32.86    52 Week Low $ 
Day High $33.11    P/E N/A 
Day Low $32.66    EPS $ 
Volume 2,706,951